In the presently accepted view, the H-2 gene complex is divisible by recombination into six regions, each marked by a genetic locus controlling a distinct function or product ( Fig . 1) (1) . Regions K and D determine the classical H-2 alloantigens, defined serologically and by graft rejection (loci H-2K and H-2D) (2, 3) . The S region controls qualitative and quantitative variations in a serum protein (Ss-Slp locus) (4) . The capacity to respond to synthetic polypeptides and various other antigens is governed by regions I-A and I-B (loci Ir-IA and Ir-IB) (5-7) . These latter two regions also determine a unique membrane alloantigenic system, called la (loci Ia-1 and la-2) (8) (9) (10) (11) . A third region for the control of la antigens, I-C, has recently been postulated (Ia-3 locus) (1, 12) . This current interpretation of the H-2 system assumes that only two regions determine H-2 antigens . Early maps of the H-2 gene complex depicted multiple regions for the control of H-2 specificities (3, 13, 14) . These maps were constructed with the implicit assumption that no cross-reactivity occurred between the products of separate regions, i.e ., that the genetic determinant for reactivity with a given antiserum always mapped in a single consistent position on the chromosome . In 1966, Shreffler et al . (15) noted certain inconsistencies in these linear maps, and suggested that genes controlling one particular H-2 specificity might perhaps be localized at both the H-2K and H-2D ends of the complex. This theme was later elaborated (16) , and a two-region model for the control of H-2 determinants, based on the assumption of H-2K-H-2D cross-reactivity, was formally proposed to explain H-2 recombinant data (17, 18) . The assumption of cross-reactivity between H-2K and H-2D eliminated the necessity for additional "central" regions for control of H-2 determinants . Demant et al . (19) , Snell et al . (20) , and Stimpfling (21) also proposed that genes coding for similar determinants might map at opposite ends of the complex, and Snell et al . (22) pointed out in addition that the "private" H-2 specificities could all be arranged into two segregant series .
Evidence favoring the two-region interpretation comes from three sources: (a) Skin grafts survive indefinitely when exchanged between combinations in which the multi-region model predicts incompatibility for regions other than H-2K or H-2D (21, (23) (24) (25) (26) . A weakness with this approach is that the multi-region maps were constructed on the basis of serological data, not skin graft data . (b) Antibody against an unrelated H-2 source, but reactive with H-2Kk determinants, can be absorbed by antigen (20) . This indirect demonstration of cross-reactivity has clearly shown H-2.1-like activity at opposite ends of the H-2 complex. Other such serological data could likewise be interpreted as implicating H-2K-H-2D cross-reactivity (15, 16, 19, 20, 27, 28) . (c) Biochemical data reveal only two H-2 glycoprotein molecules, both of which express multiple specificities (29) . Since antigenic activity resides in the protein moiety, and no evidence for subunit construction has been found, the H-2 antigens appear to be single polypeptide products of two discrete structural genes.
The key assumption distinguishing the multi-region model from the two-region model for control of H-2 determinants is that serological cross-reactivity occurs between the products of the H-2K and H-2D loci. In order to test this assumption, and provide further evidence supporting the two-region model, antisera were prepared against determinants controlled by one region (e.g. H-2K), and then tested in strain combinations which expressed determinants controlled by the other region (e.g. H-2D) . Preliminary results with a few combinations have been reported (30) . This paper presents extensive data which confirm the existence of H-2K-H-2D cross-reactivity in many combinations, and thus validate the assumption on which the two-region interpretation was predicated .
Materials and Methods
Mice . All mice utilized in this study are maintained at the University of Michigan . These lines, together with the abbreviations used in this paper, are listed in Table 1 .
Genetic Notation. This notation is based upon the recommendations of Klein et al . (32) . H-2K and H-2D refer to genetic loci . Each locus is defined on the basis of control of a distinct function or product and separation from other loci in the H-2 complex by recombination. For brevity in the text of this paper, the locus symbols are frequently shortened to K and D. Alleles at the H-2K and H-2D loci are normally designated by a superscript denoting the haplotype or origin (e .g . H-2Kk, H-2Dd) . For convenience in this paper, the allele symbols will be abbreviated (e.g . Kk, Dd). The terms H-2K or K region and H-2D or D region refer to the segments of chromosome defined by intra-H-2 recombinations which have separated the specific marker loci (i .e . H-2K or H-2D) from adjacent loci . (1) . Lower case letter indicates haplotype origin of each region, i .e ., recombinant haplotype h4 has the K region of H-2k, I-A region of H-2k, I-B region of H-2°, etc. the right of the Ss gene, toward the H-2D marker gene . The H-2 haplotype is normally designated by a superscript lower case letter or combination of letter(s) and number (e .g . H-2k, H-2,+, etc.) . For brevity and convenience in the text of this paper, haplotype symbols will also be designated simply by the italicized superscript symbol printed on line with the text (e .g . k, h4, etc.) .
Immunizations. Animals, 15 to a group, were presensitized with a suspension of spleen and lymph node cells injected intraperitoneally (1 donor/15 recipients, approximately 10' cells/mouse) . After 4 wk, the mice received three additional weekly injections, and were bled 1 wk after the fourth injection. Thereafter, animals were reimmunized every 3rd wk, and were bled 1 wk after each booster. A minimum of eight injections was given in each group. In order to maximize chances of detecting weak cross-reactions, bleedings from each individual mouse were assayed for cross-reactive cytotoxic activity . Those bleedings exhibiting strong or moderate activity were pooled and stored at -80°C until further tested . A list of antisera examined for H-2K-H-2D cross-reactivity can be found in Table  II . In F, control combinations designed to test for shared determinants, immunizations were performed with irradiated donor cells (15,000 R) . This treatment was employed to prevent potential complicating antibodies resulting from graft-vs .-host reactions. The irradiated cells were found to be capable of eliciting a strong humoral response .
Dye Exclusion Microcytotoxic Test . A two-stage dye exclusion microcytotoxic test was performed as described by Amos et al . (33) , with some modifications (34) . Cell suspensions were prepared by teasing apart lymph nodes (axial, brachial, inguinal, mesenteric) in medium 199 fortified with 2% fetal calf serum and 1% antibiotic -antimycotic mixture (Grand Island Biological Co ., Grand Strain* Abbreviation Island, N.Y .), separating on a Ficoll-isopaque gradient (35) , and adjusting to a final cell concentration of 5 x 10 , cells/ml . Antisera and nonimmune serum controls were titrated by doubling dilutions, and 2-j1 aliquots transferred to wells in microtest tissue, culture plates (Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) . All work was conducted at 4°C except where indicated. 2 pl of the cells were added to each well, and the plates incubated at 37°C for 15 min. A two-stage test was performed by washing with serum-free medium before the addition of complement . Rabbit complement, either unabsorbed or absorbed with agarose-EDTA (36), was used. After the addition of 2 g1 of complement, the reaction mixture was incubated at 37°C for 30 min. This reaction was terminated by the addition of cold medium 199 (with fetal calf serum) in which the vital dye, Nigrosin, had been dissolved (0 .1%) . The number of live and dead cells was determined, and the percent cell lysis calculated . Nonimmune serum controls routinely yielded a baseline of 10% or less cell death. Antiserum titers were calculated as the dilution of serum giving 50% of the maximum specific lysis. Hemagglutination . (37) .
Skin Grafting. Tail skin grafts (I cm 2) were placed on the right and/or left dorsal flanks of mice anesthesized with Nembutal according to the method of Billingham and Medawar (38) . Grafts were secured with collodion, and protected with latex-gauze bandages . I wk after grafting, this dressing was removed, the excess collodion gently peeled off, and an ordinary Band-Aid applied for a few days to protect the graft from scratching. Graft survival was based on three criteria : (a) scale survival, (b) hair growth, and (c) pigmentation . Failure to exhibit all of these characteristics constituted the basis for classifying a graft as rejected . Chronic hair or scale loss implicated weak incompatibility .
Experimental Design . Representative recombinant and parental lines utilized in this analysis are graphically depicted in Fig. 2. (Only the D, S, and K regions of the complex are included). Two types of combinations can be set up to screen for serological cross-reactivity between the K and D ends . First, one can immunize parental lines (e .g . 1310) with tissue from one of the recombinant strains (e .g . 4R), and then test this serum (e .g . 1310 anti-4R) with tissue from the reciprocal recombinant line (e .g . HTI) (Fig. 2 A) . In this combination, we are testing for the ability of antibody produced against determinants controlled by the K end of H-2'p (anti-Kk) to react with antigen encoded by the D end of H-2°(D°) . Note that donor, recipient, and target strains all share the same S region ; i .e ., we are immunizing and testing across a "gap"' for S. Consequently, if one observes a reaction in this combination, one can assert that antibody directed against some determinant controlled by a gene to the left of S reacts with some determinant encoded by a gene to the right of S. A possible alternative to this interpretation is dealt with and excluded in the next section (Controls) .
A second type of combination which can be examined involves immunizing a recombinant line (e .g . 2R) with tissue from one parent (e .g. B10.A), and then testing this antiserum (e .g . 21?
Red cell agglutination was assayed by the polyvinyl pyrrolidone (PVP) method ' The term "gap" is used here in the same sense as that introduced by Demant et al . (24) . anti-BIO .A) with target cells derived from the second parent (e .g . 1310) ( Controls . Most strain combinations in this analysis were selected such that immunization and testing took place across a gap for the S region . A positive reaction in this case would be interpreted as evidence for cross-reactivity between the K and D products . The only tenable alternative to this interpretation would be that donor and test strains share some histocompatibility gene missing from the recipient . This could occur if recombination had involved a double, triple, or unequal crossover event. For example, suppose haplotype h4 carried by strain 4R was derived from a double or triple crossover ( Fig . 3 A, B) . One could then argue that reactivity of a B10 anti-5R (b anti-i5) serum with 411 target cells simply reflected the sharing of some common determinant, Xd, and not cross-reactivity between the H-2D and H-2K antigens . An unequal crossover, deleting some segment controlling membrane alloantigens from 4R, is also possible (Fig . 3 C) . Reactivity of a 411 anti-1310 (h4 anti-b) serum with B10.A (a) targets could in that case reflect a direct or cross-reaction between Xb and Xk products, and not H-2D and H-2K products .
Although any one of these rare chromosomal rearrangements is possible, data presented in Table III argue against such occurrences. Tissue from B10 donors is compatible with (4R x 5R)F 1 recipients (Group I) . Skin grafts survive permanently, and no humoral immunity is detected in hyperimmunized animals. Thus,
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. Recombinant Anti parent Dd C. h4 as on unequal crossover (deletion) . no detectable reaction is directed against the postulated Xb product, arguing against any double or triple crossover. Failure of (411 x 5R)F, hybrids to demonstrate reactivity against either parental B10 (Group I) or B10.A tissue (25) suggests that an unequal crossover in 411, deleting a gene controlling some membrane determinant, is also unlikely . Lack of humoral or graft responses in the combinations included in Group I and Group 11 also argues against double, triple or unequal crossover origins for the 211 and 511 recombinants, and further implies that no H-gene mutation has occurred since the establishment of the 211, 411, 511, B10, and B10.A strains.
Combinations included in Group III did produce cytotoxic, nonhemagglutinating antibody capable of lysing approximately 70% of lymph node targets. This behavior is unlike that of classical H-2 antibody (see description in K-D Cross-Reactivity section) . Reactivity in these two combinations has been attributed to a new H-2-linked antigen system called la . 2 The weak graft incompatibility observed with both combinations may implicate a minor transplantation role for some genes in the segment between H-2K and H-2D .
It was not possible to test the d/k recombinants for compatibility with parental hybrids in all combinations, since these haplotypes are on three different inbred strain backgrounds (Group IV and Group V) . However, in those combinations tested, no serologically detectable responses occurred . Unexpectedly, multiple cases of weak graft incompatibility were observed . The most critical combination is (1310.1311 x B10.D2)F, hybrids grafted with B10.A skin (Group IV). Two of 10 grafts were rejected at 48 and 90 days . One of the remaining eight grafts showed signs of chronic hair and scale loss, while the rest exhibited good viability. Since B10.A tissue is perfectly compatible with other B10 congenic recipients (Group I), and B10.D2 tissue is compatible with (BIO .A x C3H.OH)F, hosts (Group V), it seems unlikely that this antigenic disparity resides in the 1110 background of strain BIO.A . The a haplotype is a postulated recombinant between d and k (13) . Perhaps the haplotypes from which a was derived were slightly different from those in B10.D2 (H-2d) and B10.BR (H-2k), or perhaps mutation has since altered one of the haplotypes . We cannot distinguish between these possibilities . The design used here to screen for possible shared determinants in certain combinations is similar to that employed by other investigators who tested for (21, (23) (24) (25) (26) . According to the multi-region H-2 model, one would predict that humoral immunity should be observed in the following combinations ; (2R x 5R)F, anti-1310, (4R x 5R)F, anti-1310, (4R x HTI)F, anti-1310, and (B10 .A x C3H.OH)F, anti-B10 .D2 . After prolonged immunization, no cytotoxic or hemagglutinating antibody was detected in any of these combinations (Table 111) . These serological data thus complement the previous skin graft data in failing to demonstrate immunity against those "central" H-2 regions postulated under the older model.
In sum, these control immunizations suggest that no mutation or unusual recombinatory event (i .e . double, triple, or unequal cross-over) transpired in the establishment of the strains used in the experiments which follow . These observations imply further that the reactivity observed in the test combinations reported below is due to cross-reactivity between the products of two distinct genes, H-2K and H-2D, and not to direct reactions between the products of shared genes .
K-D Cross -Reactiuity . Hemagglutination and cytotoxic data demonstrating extensive and reciprocal K-D cross-reactivity are summarized in Table IV Wherever a cross-reaction was observed, a gap exists at least for the S region, or, in the case of B10 anti-5R, a gap for I-B. In each case, one can infer that antibody directed against the product of some gene to the left of S or I-B reacts with an antigen controlled by a gene to the right of S or I-B, or vice versa. Several observations strongly suggest that the products of the H-2K and H-2D genes are involved in this reactivity, and not the closely linked Ia or Tla genes, which also control membrane alloantigens . First, no Ia determinants have been reported which map to the right of S. Second, in most combinations tested, greater than 90% kill of lymph node targets is observed . Ia antisera routinely give a maximum kill of 40-70% (8) . Third, Ia determinants are not present on red cells (8, 10) . Most cases of cross-reactivity are detected by hemagglutination as well as by cytotoxicity. Complications attributable to Tla are most unlikely, since Tla antigens are not expressed on lymph node lymphocytes, which were the target cells utilized in the cytotoxic assay (39) . Identification of the cross-reacting specificities in these antisera as known H-2 public specificities lends further credence to this interpretation . Absorption analyses have revealed cross-reacting H-2.3, 5, 29, and 36 antibodies in these sera .I Raw data from both the hemagglutination and cytotoxic assays are included in Table IX (djb   recombinants) . Antiserum titers are reported as the reciprocal of the endpoint dilution . Cytotoxic titers were determined by the dilution of antiserum giving 50% of the maximum specific lysis. Hemagglutination titers are based on the last antiserum dilution giving a positive reaction . In the discussion below, reciprocal antiserum combinations will be considered together to emphasize the generally reciprocal nature of the presence or absence of K-D cross-reactivity . B10 anti-5R (AS-37), B10 Anti-4R (AS-49). Both antisera gave positive cytotoxic and hemagglutination cross-reactions with target cells from the appropriate strain (Table IV, Table VII) . Preliminary results suggesting D-K cross-reactivity in the B10 anti-5R combination were reported previously (30) . No cross-reactive antibody was found in early bleedings in the B10 anti-4R combination. Results with later bleedings demonstrated a positive reaction . These antisera thus demonstrate reciprocal Kk-Dd cross-reactivity . (Table IV, Table VII ) . However, this antiserum did give weak cytotoxicity with B10.D2 lymphocytes. The reciprocal antiserum, AS-25, gave a weak cytotoxic reaction with 211 target cells. These weak reactions probably reflect H-2 cross-reactivity, unless la determinants are situated to the right of S. These data thus imply weak one-way cross-reactions of anti-D°with the Kd product and of anti-K°with the D°product.
BIO.A Anti-2R (AS-28), B10.A Anti-5R (AS-25) . When tested with 5R target cells, AS-28 exhibited no reactivity
2R Anti-BlO .A (AS-1), 4R Anti-BIO (AS-66). Evidence for K-D cross-reactivity is apparent with both antisera (Table IV, Table VII - §  ------720  0  B10.D2  --0  0  0  3,600  360  0  640  B10.A  --500  15,000  ---0  0  A.AL  8,400  1,350  -------OH  --150  180  120  0  0  --OL  280  9,000  ---0  0  --5R  --110  -155  ----2R  --------0   Titers by hemagglutination$  C3H  0  0  ---40  640  --B10.BR  -------0  0  B10.D2  --0  0  0  >2,560  160  0  80  BIO.A  --160  >2,560  ---0  0  A.AL  > 2,560  640  -------OH  --160  320  320  0  0  --OL  160  Tril  ---0  0  --5R  --0  -0  ----2R  - 
Titers by hemagglutination results in this study was the cytotoxic reactivity of AS-66 with 211 lymphocytes (Table VII) . Strains 211 and 411 are identical at the H-2K and H-2D loci (Table 1) . Therefore, this reaction should not be directed against the products of these genes. The low level of cytotoxic kill (50%), and lack of hemagglutination with 211 red cells, may be suggestive of la reactivity . Moderate cytotoxic killing and no hemagglutination was also obtained with cells from a second target strain, 1310.1311 (Table VII) . Absorption in strain KBR cleared this reactivity, suggesting that the gene controlling the reactive determinant in 1310.1311 is positioned to the left of H-2D . Failure of 211 tissues to absorb for 1310 .1311 lymphocytes placed this gene to the right of I-B . However, AS-66 also had both cytotoxic and hemagglutinating activity for target cells from B10.A, the test strain for H-2 cross-reactivity . In vivo absorption in strain 211 did not clear this activity (Table  VII) . These data therefore also indicate a reciprocal K°-Dd cross-reactivity . 511 Anti-B10 (AS-10), 511 Anti-B10 .A (AS-12) . A weak but reproducible cytotoxic cross-reaction was observed with AS-10 ( Table IV, Table VII ) . In this particular strain combination, la antibody potentially reactive with B10.A could be present (anti-I-C°) . However, strain AQR failed to clear reactivity for B10.A, thus suggesting H-2 reactivity . A negative reaction was observed in the reciprocal direction (AS-12) . These data suggest a one-way cross-reaction of anti-D°with Kk .
C3H across a gap for the S region in both assay systems indicate reciprocal cross-reactivity between Kk and Dk (Table V, Table VIII) . MOM Anti-5R (AS-123) . This antiserum is included in Table V and Table  VIII to demonstrate K°-D" reactivity, and represents a second reciprocal partner of AS-77 .
OH Anti-B10M (AS-51), OL Anti-C3H (AS-54) . The reciprocal cross-reactivity with these combinations in both assay systems after absorption with OL (AS-51) and OH (AS-54) to create a gap situation (Table V, Table VIII ) is comparable to that reported above with AS-37 and AS-49 (Table IV) . We thus have a second, independent example of reciprocal Kk-Dd reactivity .
B10.A Anti-B10M (AS-45), B10.A Anti-BIOM (AS-43) . When tested with B10 .D2 and B10.BR respectively, no reaction was observed, suggesting the absence of cross-reactivity between Dk and Kd ( Table V, Table VIII) .
(D2.GD x R103)F, Anti-OH (AS-131), (D2.GD x R103)F, Anti-B10M (AS-132), (D2.GD x R103)F, Anti-B10 (AS-134) . Positive cytotoxic and/or hemagglutination reactions with all target strains tested provide additional examples of specific K-D cross-reactivity (Table VI, Table IX ) . For example, AS-132 gives a third, independent demonstration of cross-reactivity between anti-Dd antibody and Kk antigen (compare with AS-37) (Table IV) and AS-51 (Table V) .
Unreactiuity of Kb Cells in Hemagglutination . Poor reactivity of B10 red cells in the hemagglutination assay was recognized in early studies of H-2 serology (40) . In particular, anti-H-2 .5 antisera routinely fail to agglutinate K°targets, regardless of strain background (41, 42) . Data in this study further illustrate this phenomenon . Antisera against Dd or Dk all gave positive cytotoxic reactions but negative hemagglutination with Kb targets (AS-1, AS-77, AS-131, AS-132). Despite the fact that Kb tissue was used as the donor in the preparation of AS-25, AS-66, AS-123, and AS-134, no hemagglutinating activity was found with K°red cells. These same antisera were cytotoxic for Kb target cells, however, and AS-66, AS-123, and AS-134 did have hemagglutinating activity for other red cell types . In contrast, when Db tissue was used as the donor, good hemagglutinating activity was found with Db targets (AS-10, AS-28) .
Discussion
A summary of the K-D cross-reactivity detected this study is presented in Table X . Two points are striking . (a) The observed cross-reactivity is extensive. 13 of 18 possible comparisons exhibited cross-reactivity between H-2K and H-2D . In some cases, multiple combinations provide independent demonstrations of cross-reactivity . For example, AS-37, AS-51, and AS-132 all show reactivity between anti-Dd antibody and Kk antigen. On the basis of strong cytotoxic kill and/or positive red cell agglutination, 10 of these combinations revealed unequivocal reactivity between the products of the H-2K and H-2D genes. In these particular combinations, the cross-reactive entities have been identified as H-2 public specificities H-2.3, 5, 29, and 36 . 3 Three combinations exhibited weak cytotoxic cross-reactivity . To date, no la-like activity has been mapped to (Table X) . Perhaps the presence of these highly cross-reactive determinants in the recipient blocked formation of potential cross-reactive antibody . As additional recombinants involving other haplotypes become available, cross-reactivity may also be found in these presently unreactive combinations . Products of alternative alleles at the same locus (H-2K or H-2D) also, of course, share cross-reactive public specificities (2, 17) . Dual comparisons between the different H-2K alleles included in this study (K°, Kd, Kk) reveal that two out of three of these pairs share a common specificity. A similar result is found for comparisons between the different H-2D alleles studied (D°, Dd, D'p) These estimates approximate that found in this report for cross-reactivity between the products of the H-2K and H-2D loci . If this cross-reactivity reflects structural homology, it would suggest that the similarity between the products of different alleles at the same locus is no greater than that between products of the two different loci. Biochemical studies seem to be consistent with this interpretation. Nathenson and Cullen (29) have reported that preliminary peptide maps reveal almost as much similarity between the products of the H-2K and H-2D genes as between the products of different alleles at H-2D . These data are precisely what one would expect if the H-2K and H-2D genes arose through duplication of a common ancestral gene and were both concomitantly modified by mutation. Complete amino acid sequencing of these gene products may be required to resolve this problem .
The cytotoxic reaction of 411 anti-B10 (AS-66, map between these two loci . The absence of red cell agglutination and the maximum kill of 50% with 211 lymph node targets would be consistent with the behavior of an la reaction . Since no la determinants have been localized to the right of S, these data may reflect a cross-reaction of antibody directed against products of the I-A region with determinants controlled by I-B or I-C. Reactivity with the I-C region is implicated from results obtained with a second target strain, B10.BR. Alternatively, reactivity in this combination might reflect a cross-reaction between H-2 antibody (anti-H-2K) and an la determinant (I-C antigen) . This alternative appears less likely, since the molecules encoded by these two systems are biochemically distinct . Regardless of whether anti-la or anti-H-2 antibody is involved, this reactivity suggests serological cross-reactivity with the product of a gene other than H-2K or H-2D . Attempts to demonstrate K-D cross-reactivity by skin graft rejection have also been successful . 4 Prior sensitization of a recipient with tissue-bearing H-2K determinants results in the accelerated rejection of a graft expressing cross-reactive H-2D determinants, and vice versa . Using an experimental design comparable to that employed here, Nabholz et al . (43) have demonstrated a similar K-D cross-reaction in vitro in the cell-mediated lympholysis assay. Prior sensitization of lymphocytes with H-2K tissue can generate T-"killer" cells capable of destroying targets expressing cross-reactive H-2D determinants . This supports the idea that the accelerated graft rejection observed in vivo may be due to cross-sensitization at the cell-mediated level of immunity .
In conclusion, extensive and reciprocal serological cross-reactivity has been demonstrated between the products of the H-2K and H-2D loci . Controls designed to test for possible shared determinants in the combinations examined make alternative interpretations most unlikely . These data validate the key assumption underlying the current two-region interpretation for control of the classical H-2 specifications . The observation of apparently comparable crossreactivity between la determinants serves as a warning that the pitfalls encountered in early H-2 serology may also appear in the analysis of this new antigenic system .
Summary
Serological cross-reactivity between the products of the H-2K and H-2D genes has been demonstrated by a design in which antibody was produced against determinants controlled by one locus (e .g . H-2K"), and then tested against the product of the opposite locus (e .g . H-2Dd) . A total of 13 out of 18 such test combinations exhibited H-2K-H-2D cross-reactivity . The presence or absence of cross-reactivity was reciprocal in most cases (i .e . antibody directed against the H-2K" gene product reacted with H-21)d determinants, and antibody directed against the H-2D d gene product reacted with H-2Kk determinants) . An la-like reaction was detected with one antiserum which implied possible cross-reactivity between the products of two discrete la genes.
